inVentiv to start roadshow Monday for $720 million eight-year notes

By Paul A. Harris

Portland, Ore., Sept. 21 – A roadshow starts on Monday for inVentiv Group Holdings, Inc.'s $720 million offering of eight-year senior notes (Caa2), according to a syndicate source.

The Rule 144A and Regulation S for life offering is set to price during the Sept. 26 week.

Credit Suisse Securities (USA) LLC, Goldman Sachs & Co., BofA Merrill Lynch, Morgan Stanley & Co. LLC, Barclays and Jefferies LLC are the joint bookrunners.

The notes become callable after three years at par plus 50% of the coupon and feature a three-year 40% equity clawback and a 101% poison put.

The Burlington, Mass.-based provider of clinical, consulting and commercial services to the health care industry plans to use the proceeds to refinance debt and fund Advent International's partial acquisition of inventive.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.